Floatz logo

IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(1-7F9) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(1-7F9) LIGHT CHAIN, DIMER

Smoldering Multiple Myeloma

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

31 Active assets in the Smoldering Multiple Myeloma cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Regeneron Pharmaceuticals
Phase 3BB
FILGRASTIM
Regeneron Pharmaceuticals
Phase 3BB
Linvoseltamab
Regeneron Pharmaceuticals
Phase 3BB
cc-5013
Irene Ghobrial, MD
Phase 3BB
DARATUMUMAB
Regeneron Pharmaceuticals
Phase 3BB

View all 48 →

Same molecule, other indications

IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(1-7F9) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(1-7F9) LIGHT CHAIN, DIMER is also rated in:

plasma cell myelomaDormant
CCC
Indicative ·
53 / 100
View asset →
First or Second RelapseDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemiaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →